Logo image of ALGEC.PA

GECI INTERNATIONAL (ALGEC.PA) Stock Fundamental Analysis

EPA:ALGEC - Euronext Paris - Matif - FR001400M1R1 - Common Stock - Currency: EUR

3.96  0 (0%)

Fundamental Rating

3

Overall ALGEC gets a fundamental rating of 3 out of 10. We evaluated ALGEC against 27 industry peers in the Professional Services industry. Both the profitability and financial health of ALGEC have multiple concerns. ALGEC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALGEC was profitable.
ALGEC had a positive operating cash flow in the past year.
In multiple years ALGEC reported negative net income over the last 5 years.
In the past 5 years ALGEC reported 4 times negative operating cash flow.
ALGEC.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

1.2 Ratios

The Return On Assets of ALGEC (6.42%) is better than 74.07% of its industry peers.
With a decent Return On Equity value of 19.84%, ALGEC is doing good in the industry, outperforming 74.07% of the companies in the same industry.
Industry RankSector Rank
ROA 6.42%
ROE 19.84%
ROIC N/A
ROA(3y)-2.06%
ROA(5y)-5.64%
ROE(3y)-30.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALGEC.PA Yearly ROA, ROE, ROICALGEC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

The Profit Margin of ALGEC (4.65%) is better than 70.37% of its industry peers.
ALGEC's Profit Margin has improved in the last couple of years.
With a Gross Margin value of 19.83%, ALGEC perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
ALGEC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 4.65%
GM 19.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.57%
PM growth 5YN/A
GM growth 3Y-5.81%
GM growth 5Y-7.26%
ALGEC.PA Yearly Profit, Operating, Gross MarginsALGEC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

3

2. Health

2.1 Basic Checks

ALGEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALGEC has more shares outstanding
ALGEC has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALGEC has an improved debt to assets ratio.
ALGEC.PA Yearly Shares OutstandingALGEC.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
ALGEC.PA Yearly Total Debt VS Total AssetsALGEC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.40, we must say that ALGEC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALGEC (0.40) is worse than 81.48% of its industry peers.
The Debt to FCF ratio of ALGEC is 5.92, which is a neutral value as it means it would take ALGEC, 5.92 years of fcf income to pay off all of its debts.
ALGEC has a Debt to FCF ratio (5.92) which is comparable to the rest of the industry.
ALGEC has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALGEC (0.14) is better than 92.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 5.92
Altman-Z 0.4
ROIC/WACCN/A
WACC5.88%
ALGEC.PA Yearly LT Debt VS Equity VS FCFALGEC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

A Current Ratio of 0.80 indicates that ALGEC may have some problems paying its short term obligations.
ALGEC has a Current ratio (0.80) which is in line with its industry peers.
ALGEC has a Quick Ratio of 0.80. This is a bad value and indicates that ALGEC is not financially healthy enough and could expect problems in meeting its short term obligations.
ALGEC's Quick ratio of 0.80 is in line compared to the rest of the industry. ALGEC outperforms 44.44% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
ALGEC.PA Yearly Current Assets VS Current LiabilitesALGEC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2

3. Growth

3.1 Past

ALGEC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.72%, which is quite impressive.
The Revenue has grown by 10.43% in the past year. This is quite good.
ALGEC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.29% yearly.
EPS 1Y (TTM)114.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.79%
Revenue 1Y (TTM)10.43%
Revenue growth 3Y10.84%
Revenue growth 5Y-5.29%
Sales Q2Q%-17.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEC.PA Yearly Revenue VS EstimatesALGEC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.50 indicates a rather cheap valuation of ALGEC.
ALGEC's Price/Earnings ratio is rather cheap when compared to the industry. ALGEC is cheaper than 96.30% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALGEC to the average of the S&P500 Index (24.21), we can say ALGEC is valued rather cheaply.
Industry RankSector Rank
PE 5.5
Fwd PE N/A
ALGEC.PA Price Earnings VS Forward Price EarningsALGEC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

74.07% of the companies in the same industry are more expensive than ALGEC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.71
EV/EBITDA N/A
ALGEC.PA Per share dataALGEC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALGEC!.
Industry RankSector Rank
Dividend Yield N/A

GECI INTERNATIONAL

EPA:ALGEC (5/9/2025, 7:00:00 PM)

3.96

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.57%
Ins Owner ChangeN/A
Market Cap4.04M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.5
Fwd PE N/A
P/S 0.18
P/FCF 9.71
P/OCF 9.2
P/B 0.76
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.72
EY18.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.41
FCFY10.3%
OCF(TTM)0.43
OCFY10.87%
SpS22.28
BVpS5.22
TBVpS-1.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.42%
ROE 19.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.65%
GM 19.83%
FCFM 1.83%
ROA(3y)-2.06%
ROA(5y)-5.64%
ROE(3y)-30.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.57%
PM growth 5YN/A
GM growth 3Y-5.81%
GM growth 5Y-7.26%
F-Score6
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 5.92
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 39.39%
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 0.4
F-Score6
WACC5.88%
ROIC/WACCN/A
Cap/Depr(3y)74.78%
Cap/Depr(5y)48.89%
Cap/Sales(3y)0.72%
Cap/Sales(5y)0.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.43%
Revenue growth 3Y10.84%
Revenue growth 5Y-5.29%
Sales Q2Q%-17.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3130.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y135.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y138.17%
OCF growth 3YN/A
OCF growth 5YN/A